The Food and Drug Administration is trying to help mitigate the shortage of EpiPens, those auto-injecting devices used to treat allergic reactions to things like peanuts and bee stings. It’s extended by four months the expiration date for some EpiPen products. The FDA got data from EpiPen maker Mylan that convinced them some of the devices already on the market will work a bit longer.

Click the audio player above to hear the full story.